Childhood Cancer

You are here

Home » Grants » All grants tagged with "Medulloblastoma"

All grants tagged with "Medulloblastoma"

Pre-clinical Testing of Novel Glutamine Metabolic Inhibitors in MYC-driven Medulloblastoma
Eric Raabe, MD/PhD & Dr. Barbara Slusher, PhD
The Johns Hopkins University School of Medicine
Innovation Grants, Awarded 2016
Targeting Eya2 to Inhibit c-Myc driven Medulloblastoma Tumor Progression
Melanie Vincent, PhD
University of Colorado Denver
Young Investigator Grants, Awarded 2016
Control of Medulloblastoma through the Regulation of Tumor Debris
Megan Sulciner
Dana-Farber Cancer Institute
POST Program Grants, Awarded 2016
Site-specific Hyper-phosphorylation of IRF2BP2 Modulates Tumor PD-L1 Expression in Medulloblastoma
Daniel Kingsley
Case Western Reserve University
POST Program Grants, Awarded 2016
Histone H3.3 Targeted Therapy for Pediatric High-grade Gliomas
Paul Knoepfler, PhD
University of California, Davis Medical Center
Innovation Grants, Awarded 2015
Regulation of Tumor Debris Mediated Inflammation as a Therapeutic Modality in Medulloblastoma
Mark Kieran, MD, PhD & Dipak Panigrahy, MD
Dana-Farber Cancer Institute
Innovation Grants, Awarded 2015
Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy
Timothy Gershon, MD, PhD
University of North Carolina
Innovation Grants, Awarded 2015
Characterizing Resistance Mechanisms to BET-Bromodomain Inhibition in MYC-amplified
Rameen Beroukhim, MD,PhD
Broad Institute
Innovation Grants, Awarded 2015
The YB1 Way of Surviving Radiation, Pediatric Brain Tumor Resistance and Recurrence
Abhinav Dey, PhD
Emory University
Young Investigator Grants, Awarded 2015
Understanding the Role of Translational Control in Humanized Mouse Models for Medulloblastoma
Ozlem Aksoy, PhD
University of California San Francisco
Young Investigator Grants, Awarded 2015

Pages

All childhood cancer types

Featured Hero

Sam Glossi

At 3-and-a-half years old, Sam's parents found a large lump on Sam's abdomen. He underwent surgery to remove it and was cancer-free for a short time. When the cancer returned, it was treated like stage 4 neuroblastoma. Sam has been cancer-free since 2017!
Read more »